205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.73%
Revenue growth below 50% of MRVL's 9.11%. Michael Burry would check for competitive disadvantage risks.
2.18%
Cost growth less than half of MRVL's 7.31%. David Dodd would verify if cost advantage is structural.
1.31%
Gross profit growth below 50% of MRVL's 10.71%. Michael Burry would check for structural issues.
-0.41%
Margin decline while MRVL shows 1.46% expansion. Joel Greenblatt would examine competitive position.
6.34%
Similar R&D growth to MRVL's 6.18%. Walter Schloss would investigate industry innovation requirements.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.03%
Operating expenses growth 1.1-1.25x MRVL's 4.48%. Bill Ackman would demand justification.
3.17%
Total costs growth 50-75% of MRVL's 6.18%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
-1.29%
D&A reduction while MRVL shows 0.10% growth. Joel Greenblatt would examine efficiency.
-2.14%
EBITDA decline while MRVL shows 14.10% growth. Joel Greenblatt would examine position.
-3.80%
EBITDA margin decline while MRVL shows 4.57% growth. Joel Greenblatt would examine position.
-2.41%
Operating income decline while MRVL shows 19.85% growth. Joel Greenblatt would examine position.
-4.07%
Operating margin decline while MRVL shows 9.84% growth. Joel Greenblatt would examine position.
-37.21%
Other expenses reduction while MRVL shows 19.62% growth. Joel Greenblatt would examine advantage.
-5.29%
Pre-tax income decline while MRVL shows 19.84% growth. Joel Greenblatt would examine position.
-6.91%
Pre-tax margin decline while MRVL shows 9.83% growth. Joel Greenblatt would examine position.
-0.67%
Tax expense reduction while MRVL shows 16.08% growth. Joel Greenblatt would examine advantage.
-70.59%
Net income decline while MRVL shows 20.37% growth. Joel Greenblatt would examine position.
-71.09%
Net margin decline while MRVL shows 10.32% growth. Joel Greenblatt would examine position.
-69.48%
EPS decline while MRVL shows 21.43% growth. Joel Greenblatt would examine position.
-69.33%
Diluted EPS decline while MRVL shows 7.69% growth. Joel Greenblatt would examine position.
-3.03%
Share count reduction while MRVL shows 0.98% change. Joel Greenblatt would examine strategy.
-3.09%
Diluted share reduction while MRVL shows 0.99% change. Joel Greenblatt would examine strategy.